Myomo MYO
NYSE MYO
$1.74 -0.12 (-6.45%)
At close: Aug 20, 2026 · 11:16 AM UTC

Myomo (MYO) Net Income towards Common Stockholders (2016 - 2025)

Myomo's (MYO) quarterly Net Income towards Common Stockholders came in at -$3.7 million in Q3 2025, down 279.02% YoY from $2.0 million in Q3 2024, and up 20.92% on a QoQ basis from -$4.6 million in Q2 2025.

Myomo (MYO) Net Income towards Common Stockholders (2016 - 2025) Analysis & Trends

Myomo (MYO) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$3.7 million in Q3 2025.

  • Quarterly Net Income towards Common Stockholders fell 279.02% year-over-year to -$3.7 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$11.8 million (down 63.55% YoY) and the FY2024 annual result came in at -$7.2 million, up 18.96% from the prior year.
  • Net Income towards Common Stockholders grew to -$3.7 million in Q3 2025, from -$4.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$966409.0 in Q3 2024 to a low of -$4.6 million in Q2 2025.
  • A 5-year average of -$2.6 million and a median of -$2.8 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 65.14% — and 2025, when it plunged 312.98%.
  • Tracing MYO's Net Income towards Common Stockholders over 5 years: stood at -$3.4 million in 2021, then soared by 30.39% to -$2.3 million in 2022, then sank by 35.65% to -$3.2 million in 2023, then surged by 60.23% to -$1.3 million in 2024, then slumped by 189.16% to -$3.7 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$3.7 million (Q3 2025), -$4.6 million (Q2 2025), and -$3.5 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 621.86 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 201.00 Mn
10 Myomo 72.95 Mn 53.98 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -3.66 Mn
Jun 30, 2025 -4.63 Mn
Mar 31, 2025 -3.47 Mn
Dec 31, 2024 -1.27 Mn
Sep 30, 2024 -966,409.00
Jun 30, 2024 -1.12 Mn
Mar 31, 2024 -3.84 Mn
Dec 31, 2023 -3.19 Mn
Sep 30, 2023 -2.03 Mn
Jun 30, 2023 -1.01 Mn
Mar 31, 2023 -2.64 Mn
Dec 31, 2022 -2.35 Mn
Sep 30, 2022 -2.83 Mn
Jun 30, 2022 -2.91 Mn
Mar 31, 2022 -2.81 Mn
Dec 31, 2021 -3.37 Mn
Sep 30, 2021 -2.06 Mn
Jun 30, 2021 -2.62 Mn
Mar 31, 2021 -2.96 Mn
Dec 31, 2020 -1.70 Mn